General Information |
| Board Constituency: |
Private sector |
| Organization Type - Primary: |
Private Sector |
| Organization Type - Secondary: |
None |
| Is your organization legally registered in your country: |
Yes |
| Organization Reach: |
International |
| Organization Description: |
| We are a startup company formed to commercialize a breakthrough diagnostic technology for TB discovered by researchers at Texas A&M Health Science Center College of Medicine and Stanford University. Our philosophy is to design our diagnostics for use in resource constrained environments and are currently several applications of our technology, including a rapid POC test that promises to meet the needs of the global TB market. |
| |
| Total number of staff in your organization: |
1 - 5 |
| Number of full-time staff who are directly involved with TB: |
1 - 5 |
| Number of part-time staff who are directly involved with TB: |
0 |
| Number of volunteers who are directly involved with TB: |
0 |
| |
| What is your organization's annual budget (USD) dedicated to TB? |
$100,001-$500,000 |
| How did you hear about the Stop TB Partnership: |
Other partners |
| Why do you wish join the Stop TB Partnership: |
Technical assistance and advice |
| |
| Are you a member of a Stop TB national partnership: |
No |
| Are you in contact with your national TB programme: |
No |
| Please tell us how your organization is contributing to your country's national TB control plan: |
| In partnership with FIND and others, we are commercializing a new rapid technology for tuberculosis diagnosis that will potentially allow a rapid POC TB diagnostic. |
| |
Geographical Reach |
| Which country is your headquarters located in: |
United States of America |
| Which WHO region is the main focus of your work: |
Global |
Which countries do you do operate in:
(This includes countries you are conducting activities in) |
United States of America
|
